Literature DB >> 22197438

Age-related macular degeneration and incident cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis.

Antonio B Fernandez1, Tien Y Wong, Ronald Klein, Dorothea Collins, Gregory Burke, Mary Frances Cotch, Barbara Klein, Mehran M Sadeghi, Jersey Chen.   

Abstract

OBJECTIVE: To determine whether age-related macular degeneration (AMD) is a risk indicator for coronary heart disease (CHD) and cardiovascular disease (CVD) events independent of other known risk factors in a multi-ethnic cohort.
DESIGN: Population-based prospective cohort study. PARTICIPANTS: A diverse population sample of 6233 men and women aged 45 to 84 years without known CVD from the Multi-Ethnic Study of Atherosclerosis (MESA).
METHODS: Participants in the MESA had retinal photographs taken between 2002 and 2003. Photographs were evaluated for AMD. Incident CHD and CVD events were ascertained during clinical follow-up visits for up to 8 years after the retinal images were taken. MAIN OUTCOME MEASURES: Incident CHD and CVD events.
RESULTS: Of the 6814 persons at risk of CHD, there were 893 participants with early AMD (13.1%) and 27 patients (0.5%) at baseline. Over a mean follow-up period of 5.4 years, there was no statistically significant difference in incident CHD or CVD between the AMD and non-AMD groups (5.0% vs. 3.9%, P = 0.13 for CHD and 6.6% vs. 5.5%, P = 0.19 for CVD). In Cox regression models adjusting for CVD risk factors, there was no significant relationship between presence of any AMD and any CHD/CVD events (hazard ratio 0.99; 95% confidence interval, 0.74-1.33; P = 0.97). No significant association was found between subgroups of early AMD or late AMD and incident CHD/CVD events.
CONCLUSIONS: In persons without a history of CVD, AMD was not associated with an increased risk of CHD or CVD.
Copyright © 2012 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22197438      PMCID: PMC3314126          DOI: 10.1016/j.ophtha.2011.09.044

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  31 in total

Review 1.  The role of the atherosclerotic process in the pathogenesis of age-related macular degeneration.

Authors:  E Friedman
Journal:  Am J Ophthalmol       Date:  2000-11       Impact factor: 5.258

Review 2.  Neovascularization in human atherosclerosis.

Authors:  Pedro R Moreno; K-Raman Purushothaman; Marc Sirol; Andrew P Levy; Valentin Fuster
Journal:  Circulation       Date:  2006-05-09       Impact factor: 29.690

Review 3.  Elimination of neoangiogenesis for plaque stabilization: is there a role for local drug therapy?

Authors:  Frank D Kolodgie; Jagat Narula; Chun Yuan; Allen P Burke; Aloke V Finn; Renu Virmani
Journal:  J Am Coll Cardiol       Date:  2007-05-17       Impact factor: 24.094

4.  Age-related macular degeneration and risk of coronary heart disease: the Atherosclerosis Risk in Communities Study.

Authors:  Tien Yin Wong; Gabriella Tikellis; Cong Sun; Ronald Klein; David J Couper; A Richey Sharrett
Journal:  Ophthalmology       Date:  2007-01       Impact factor: 12.079

5.  Age-related macular degeneration is associated with incident myocardial infarction among elderly Americans.

Authors:  Yinkang Duan; Jingping Mo; Ronald Klein; Ingrid U Scott; Hung-Mo Lin; Joanne Caulfield; Manju Patel; Duanping Liao
Journal:  Ophthalmology       Date:  2006-12-20       Impact factor: 12.079

6.  Relationship between age-related macular degeneration-associated variants of complement factor H and LOC387715 with coronary artery disease.

Authors:  Jose S Pulido; Joseph P McConnell; Ryan J Lennon; Sandra C Bryant; Lisa M Peterson; Peter B Berger; Virend Somers; W Edward Highsmith
Journal:  Mayo Clin Proc       Date:  2007-03       Impact factor: 7.616

7.  Cigarette smoking and age-related macular degeneration in the EUREYE Study.

Authors:  U Chakravarthy; C Augood; G C Bentham; P T V M de Jong; M Rahu; J Seland; G Soubrane; L Tomazzoli; F Topouzis; J R Vingerling; J Vioque; I S Young; A E Fletcher
Journal:  Ophthalmology       Date:  2007-03-06       Impact factor: 12.079

8.  Age-related macular degeneration and risk for stroke.

Authors:  Tien Yin Wong; Ronald Klein; Cong Sun; Paul Mitchell; David J Couper; Hong Lai; Larry D Hubbard; A Richey Sharrett
Journal:  Ann Intern Med       Date:  2006-07-18       Impact factor: 25.391

9.  Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis.

Authors:  Judith C Sluimer; Jean-Marie Gasc; Job L van Wanroij; Natasja Kisters; Mathijs Groeneweg; Maarten D Sollewijn Gelpke; Jack P Cleutjens; Luc H van den Akker; Pierre Corvol; Bradly G Wouters; Mat J Daemen; Ann-Pascale J Bijnens
Journal:  J Am Coll Cardiol       Date:  2008-04-01       Impact factor: 24.094

10.  Age-related macular degeneration and mortality from cardiovascular disease or stroke.

Authors:  J S L Tan; J J Wang; G Liew; E Rochtchina; P Mitchell
Journal:  Br J Ophthalmol       Date:  2008-02-29       Impact factor: 4.638

View more
  12 in total

1.  Age-related macular degeneration and protective effect of HMG Co-A reductase inhibitors (statins): results from the National Health and Nutrition Examination Survey 2005-2008.

Authors:  D T Q Barbosa; T S Mendes; H R Cíntron-Colon; S Y Wang; R B Bhisitkul; K Singh; S C Lin
Journal:  Eye (Lond)       Date:  2014-02-07       Impact factor: 3.775

Review 2.  Genetics of age-related macular degeneration (AMD).

Authors:  Margaret M DeAngelis; Leah A Owen; Margaux A Morrison; Denise J Morgan; Mingyao Li; Akbar Shakoor; Albert Vitale; Sudha Iyengar; Dwight Stambolian; Ivana K Kim; Lindsay A Farrer
Journal:  Hum Mol Genet       Date:  2017-08-01       Impact factor: 6.150

3.  Thyroid function: a new road to understanding age-related macular degeneration?

Authors:  Till Ittermann; Clemens Jürgens
Journal:  BMC Med       Date:  2015-04-23       Impact factor: 8.775

Review 4.  Age-Related Macular Degeneration and Incident Stroke: A Systematic Review and Meta-Analysis.

Authors:  Antonio B Fernandez; Gregory A Panza; Benjamin Cramer; Saurav Chatterjee; Ramya Jayaraman; Wen-Chih Wu
Journal:  PLoS One       Date:  2015-11-18       Impact factor: 3.240

5.  Age-related macular degeneration and the incidence of cardiovascular disease: a systematic review and meta-analysis.

Authors:  Juan Wu; Miki Uchino; Srinivas M Sastry; Debra A Schaumberg
Journal:  PLoS One       Date:  2014-03-28       Impact factor: 3.240

Review 6.  Relation between Age-Related Macular Degeneration and Cardiovascular Events and Mortality: A Systematic Review and Meta-Analysis.

Authors:  Jie Wang; Yangjing Xue; Saroj Thapa; Luping Wang; Jifei Tang; Kangting Ji
Journal:  Biomed Res Int       Date:  2016-12-14       Impact factor: 3.411

Review 7.  Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors.

Authors:  Katie L Pennington; Margaret M DeAngelis
Journal:  Eye Vis (Lond)       Date:  2016-12-22

8.  Age-related macular degeneration and progression of coronary artery calcium: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Antonio B Fernandez; Kevin D Ballard; Tien Y Wong; Mengye Guo; Robyn L McClelland; Gregory Burke; Mary Frances Cotch; Barbara Klein; Matthew Allison; Ronald Klein
Journal:  PLoS One       Date:  2018-07-18       Impact factor: 3.240

9.  Evaluation of cardiovascular biomarkers in patients with age-related wet macular degeneration.

Authors:  Sadullah Keles; Orhan Ates; Baki Kartal; Hamit Hakan Alp; Metin Ekinci; Erdinc Ceylan; Osman Ondas; Eren Arpali; Semih Dogan; Kenan Yildirim; Mevlut Sait Keles
Journal:  Clin Ophthalmol       Date:  2014-08-25

10.  Impact of Visual Impairment and Eye diseases on Mortality: the Singapore Malay Eye Study (SiMES).

Authors:  Rosalynn Grace Siantar; Ching-Yu Cheng; Chui Ming Gemmy Cheung; Ecosse L Lamoureux; Peng Guan Ong; Khuan Yew Chow; Paul Mitchell; Tin Aung; Tien-Yin Wong; Carol Y Cheung
Journal:  Sci Rep       Date:  2015-11-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.